SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
73 hedge funds and large institutions have $121M invested in Sorrento Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
38% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $1.67M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
73
Holding in Top 10
1
Calls
$1.04M
Puts
$1.67M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$6.28M | |
| 3 | +$4.62M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.31M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.57M |
Top Sellers
| 1 | -$6.81M | |
| 2 | -$917K | |
| 3 | -$835K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$325K |
| 5 |
JPMorgan Chase & Co
New York
|
-$259K |